Dian Diagnostics released its 2024 annual performance, reporting a net loss attributable to the parent company of 357 million yuan, turning from profit to loss year-on-year
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Dian Diagnostics disclosed its 2024 annual report. During the reporting period, the company achieved revenue of 12.196 billion yuan, a year-on-year decrease of 9.04%; the net profit attributable to the parent company was a loss of 357 million yuan, turning from profit to loss year-on-year; the net profit excluding non-recurring gains and losses was a loss of 380 million yuan, also turning from profit to loss year-on-year; the basic earnings per share were -0.5790 yuan. The company plans to distribute a cash dividend of 2.50 yuan (tax included) for every 10 shares
According to the Zhitong Finance APP, Dian Diagnostics (300244.SZ) disclosed its 2024 annual report. During the reporting period, the company achieved revenue of 12.196 billion yuan, a year-on-year decrease of 9.04%; the net profit attributable to shareholders was a loss of 357 million yuan, turning from profit to loss year-on-year; the net profit excluding non-recurring gains and losses was a loss of 380 million yuan, also turning from profit to loss year-on-year; the basic earnings per share were -0.5790 yuan. The company plans to distribute a cash dividend of 2.50 yuan (including tax) for every 10 shares